Contineum therapeutics announces appointment of john healy as general counsel & corporate secretary

San diego--(business wire)--contineum therapeutics, inc. (nasdaq: ctnm), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of neuroscience, inflammation and immunology (ni&i) indications, today announced the appointment of john healy as general counsel & corporate secretary. “we are excited that john has joined contineum, as.
GM Ratings Summary
Quant
GM Quant Ranking
Sector
Industry
Quant Rating
Quant Score